Article
Ribosomal mutations in Arcanobacterium pyogenes confer a unique spectrum of macrolide resistance.
Antimicrobial agents and chemotherapy - 1 Mar 2004
Jost B Helen, Trinh Hien T, Songer J Glenn, Billington Stephen J
Abstract excerpt
Four macrolide-resistant Arcanobacterium pyogenes isolates contained A2058T, A2058G, or C2611G (Escherichia coli numbering) mutations in their 23S rRNA genes. While these mutations conferred resistance to erythromycin, oleandomycin, and spiramycin, they did not confer resistance to tylosin.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
